secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001104659-25-116217
Event type: regulatory
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

HHS sets LINZESS Maximum Fair Price at $136 per 30-day supply starting Jan 2027
-------------------------------------------------------------------------------

- MFP for LINZESS (linaclotide) is $136 for a 30-day supply, effective January 1, 2027.
- Ironwood says the MFP is in line with company expectations.
- LINZESS was selected in the latest round of IRA government price setting.
- MFP will become the new Medicare net price for the drug.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465925116217/0001104659-25-116217-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465925116217/tm2532096d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-116217

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer